Inducing Immune-Tolerance to AAV Vector Capsid for Gene Therapy of Duchenne Muscular Dystrophy

Project: Research

StatusActive
Effective start/end date1/10/1531/08/20

Funding

Jesse's Journey: £102,041, Jesse's Journey: £59,172, Jesse's Journey: £112,979

ID: 25181051